New Long-Acting diabetes shot shows promise in first human test
Disease control
Completed
This early study tested a single injection of NEX-22A, a long-acting version of the diabetes drug liraglutide, in 12 adults with type 2 diabetes. The main goal was to see how the drug moves through the body and if it is safe. Participants were on stable metformin therapy and rece…
Phase: PHASE1 • Sponsor: Nanexa AB • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC